Velocity Clinical Research Valparaiso — Valparaiso, Indiana

Velocity Clinical Research Valparaiso is a clinical research site located in Valparaiso, Indiana, United States 46383.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Velocity Clinical Research Valparaiso has participated in 24 clinical trials with 10 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease, Overweight, Obesity.

Sponsors: Amgen, Eli Lilly and Company, Bond Avillion 2 Development LP.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Valparaiso

Browse all research sites in Indiana · View every site in Valparaiso

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research Valparaiso?

Velocity Clinical Research Valparaiso has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research Valparaiso conducted?

Velocity Clinical Research Valparaiso has 24 clinical trials on record, with 10 currently active. Their work covers Atherosclerotic Cardiovascular Disease, Overweight, Obesity.

Is Velocity Clinical Research Valparaiso accredited by Crixeo Clinical Trials?

Velocity Clinical Research Valparaiso has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research Valparaiso?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.